Home › Funds › CONTRAVISORY INVESTMENT MANAGEMENT, INC. › BIIB
CONTRAVISORY INVESTMENT MANAGEMENT, INC. position in BIIB
BIOGEN INC · Health Care
CONTRAVISORY INVESTMENT MANAGEMENT, INC. reported holding 43,849 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 1.80% of its reported portfolio and ranking #18 among its reported holdings. CONTRAVISORY INVESTMENT MANAGEMENT, INC. has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How CONTRAVISORY INVESTMENT MANAGEMENT, INC.'s BIIB position evolved
CONTRAVISORY INVESTMENT MANAGEMENT, INC. first disclosed a stake in BIIB in Q1 2026 at 44,677 shares (US$8.2M). The position peaked in Q3 2026 at 43,849 shares, worth US$9.9M. Across 3 filings, CONTRAVISORY INVESTMENT MANAGEMENT, INC. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 43,849 shares valued at US$9.9M — a reduction of -480 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 44.68K | $8.19M | New |
| Q2 2026 | 44.33K | $9.58M | Reduce |
| Q3 2026 | 43.85K | $9.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.15M sh · $3.27B · Q2 2026
More on CONTRAVISORY INVESTMENT MANAGEMENT, INC.
FAQ
How long has CONTRAVISORY INVESTMENT MANAGEMENT, INC. held BIIB?
CONTRAVISORY INVESTMENT MANAGEMENT, INC. has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is CONTRAVISORY INVESTMENT MANAGEMENT, INC.'s current position in BIIB?
As of Q3 2026, CONTRAVISORY INVESTMENT MANAGEMENT, INC. holds 43.85K shares of BIIB (BIOGEN INC), valued at $9.90M, representing 1.80% of its reported portfolio and ranking #18.
Has CONTRAVISORY INVESTMENT MANAGEMENT, INC. been buying or selling BIIB?
In the latest 13F filing (Q3 2026), CONTRAVISORY INVESTMENT MANAGEMENT, INC. reduced its position in BIIB. The position peaked in Q3 2026 at 43.85K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.